Episurf Medical AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SEK 2.6 million compared to SEK 1.4 million a year ago. Revenue was SEK 5.6 million compared to SEK 3.8 million a year ago. Net loss was SEK 20.8 million compared to SEK 17.8 million a year ago. Basic loss per share from continuing operations was SEK 0.08 compared to SEK 0.07 a year ago. Diluted loss per share from continuing operations was SEK 0.08.
For the nine months, sales was SEK 7.4 million compared to SEK 4.8 million a year ago. Revenue was SEK 15.5 million compared to SEK 13.1 million a year ago. Net loss was SEK 72.9 million compared to SEK 53.6 million a year ago. Basic loss per share from continuing operations was SEK 0.27 compared to SEK 0.2 a year ago. Diluted loss per share from continuing operations was SEK 0.27.